Basics ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. IPO Date: July 18, 2013 Sector: Healthcare Industry: Pharma Market Cap: $1.84B Activated in VL: True Average Daily Range Avg Daily Range: $0.92 | 2.04% Avg Daily Range (30 D): $1.56 | 1.80% Avg Daily Range (90 D): $1.31 | 1.50% Institutional Daily Volume Avg Daily Volume: .14M Avg Daily Volume (30 D): .29M Avg Daily Volume (90 D): .33M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 43 Institutional Trades Total Inst.Trades: 2,286 Avg Inst. Trade: $2.11M Avg Inst. Trade (30 D): $5.03M Avg Inst. Trade (90 D): $4.37M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.45M Avg Closing Trade (30 D): $4.11M Avg Closing Trade (90 D): $5.25M Avg Closing Volume: 39.99K     News Aug 29, 2025 @ 12:00 PM CG Oncology’s Executive Leadership to Parti... Source: Cg Oncology Aug 8, 2025 @ 12:25 PM Cg Oncology (CGON) Q2 Loss Widens 93% Source: Jesterai May 12, 2025 @ 10:30 PM ANI Pharmaceuticals to Participate at the H.C. Wai... Source: N/A Feb 28, 2025 @ 3:37 PM ANI Pharmaceuticals Expects Strong Start To 2025, ... Source: Vandana Singh Oct 30, 2024 @ 9:00 PM ANI Pharmaceuticals to Discuss Third Quarter 2024 ... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $1.71 $1.19 $.37 Diluted EPS $1.63 $1.13 $.36 Revenue $ 826.88M $ 227.81M $ 211.37M Gross Profit $ $ $ Net Income / Loss $ 40.57M $ 26.62M $ 8.55M Operating Income / Loss $ 71.95M $ 36.24M $ 13.89M Cost of Revenue $ $ $ Net Cash Flow $ 117.63M $ 44.81M $ 68M PE Ratio 50.53     Splits Jul 18, 2013:   1:6 Jun 04, 2012:   1:6 Jun 03, 2002:   1:10